Epitomee Medical Ltd (TLV:EPIT)
Israel · Delayed Price · Currency is ILS · Price in ILA 263.00
-15.20 (-5.46%)
Nov 12, 2026, 5:24 PM IST
Epitomee Medical Market Cap
Epitomee Medical has a market cap or net worth of 78.98 million as of November 12, 2026. It is the 34,977th most valuable company in the world and the 390th biggest in Israel. Its market cap has decreased by 65.36% in one year.
Market Cap
78.98M
Enterprise Value
70.90M
Revenue
2.32M
Global Rank
Country Rank
#390 Israel
PE Ratio
n/a
ChartMarket Cap Chart
Since December 15, 2021, Epitomee Medical's market cap has decreased from 1.21B to 78.98M, a decrease of -93.45%. That is a compound annual growth rate of -42.58%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 12, 2026 | 79.91M | -56.15% |
| Dec 31, 2025 | 182.22M | -32.71% |
| Dec 31, 2024 | 270.81M | 149.63% |
| Dec 31, 2023 | 108.48M | -67.89% |
| Dec 29, 2022 | 337.85M | -63.70% |
| Dec 30, 2021 | 930.82M | -22.80% |
| Dec 15, 2021 | 1.21B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Danel (Adir Yeoshua) | 2.46B |
| Amal Holdings A.D. | 2.16B |
| Rafa Laboratories | 1.64B |
| Bait Bakfar | 1.51B |
| Bonus BioGroup | 184.57M |
| Golden House | 155.32M |
| InterCure | 149.26M |
| Rekah Pharmaceutical Industry | 115.29M |